Lot Release Certificate View

Lot Release Number 2020-08-20-0218
FDA Registered Product/Generic Name Combined Diphtheria, Tetanus and Acellular Pertussis, Hepatitis B, Inactivated Poliomyelitis and Haemophilus influenzae Type B Vaccine (Preservative-free)
Brand Name Infanrix Hexa
Dosage Strength 0.5 mL
Dosage Form Suspension for Injection (I.M.)
Registration Number BR-508
Batch/Lot Number A21CD716 (DTPa-HBV-IPV component: AC21B733B; Hib component: AHIBD380B)
Packaging Lot Packaging Lot: Box: A21CD716B Pre-filled syringe: A21LD716B MD: 11-2018 ED: 10-2021; Vial: A21FD716B MD: 04-2019 ED: 03-2022; Needles (25G x 1"): 1910055 ED: 2024-09-30
Product Expiration Date 31 October 2021
Issuance Date 25 August 2020